[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD

Key facts

Sponsor

prof. dr. Koen Van Laere

Principal Investigator

Koen Van Laere

Professor at KULeuven, department head of nuclear medicine at UZ Leuven

Intervention

[18F]-MFBG PET CT(diagnostic_test)

Enrollment

113 enrolled

Eligibility

18-85 years · All sexes

Timeline

2024 – 2026

Study locations (2)

• UZ Ghent, Ghent, Gent, Belgium
• UZ Leuven, Leuven, Vlaams-Brabant, Belgium

Collaborators

University Hospital, Ghent · Fund for Scientific Research, Flanders, Belgium · KU Leuven · Universitaire Ziekenhuizen KU Leuven

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Multiple system atrophy

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE3NCT07446894
  MSA-01 in Multiple System Atrophy
  Tokyo University
• RECRUITINGPHASE2NCT07197866
  An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy
  Teva Branded Pharmaceutical Products R&D LLC
• ENROLLING BY INVITATIONNCT07081841
  AB-1005 Long-Term Follow-up Study
  AskBio Inc
• RECRUITINGPHASE1, PHASE2NCT06831500
  Feasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease.
  Julien Bally
• RECRUITINGEARLY PHASE1NCT06765733
  The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy
  Beijing Tiantan Hospital
• RECRUITINGPHASE2NCT06868628
  A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)
  Tiziana Life Sciences LTD
• RECRUITINGNCT07353463
  Shanghai Clinical Cohort - Parkinson's Disease (Reserve)
  Ruijin Hospital
• RECRUITINGEARLY PHASE1NCT06891703
  [18F]ACI-15916 PET in α-synucleinopathies
  AC Immune SA

See all trials for Multiple system atrophy →